Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10587606 | Bioorganic & Medicinal Chemistry Letters | 2013 | 6 Pages |
Abstract
Ingenol mebutate is the active ingredient in Picato® a new drug for the treatment of actinic keratosis. A number of derivatives related to ingenol mebutate were prepared by chemical synthesis from ingenol with the purpose of investigating the SAR and potency in assays relating to pro-inflammatory effects (induction of PMN oxidative burst and keratinocyte cytokine release), the potential of cell death induction, as well as the chemical stability. By modifications of the ingenol scaffold several prerequisites for activity were identified. The chemical stability of the compounds could be linked to an acyl migration mechanism. We were able to find analogues of ingenol mebutate with comparable in vitro properties. Some key features for potent and more stable ingenol derivatives have been identified.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Xifu Liang, Gunnar Grue-Sørensen, Kristoffer MÃ¥nsson, Per Vedsø, Anke Soor, Martin Stahlhut, Malene Bertelsen, Karen Margrethe Engell, Thomas Högberg,